Goldman Sachs Group Inc. trimmed its position in Globe Life Inc. (NYSE:GL – Free Report) by 8.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 669,094 shares of the company’s stock after selling 63,408 shares during the period. Goldman Sachs Group Inc.’s holdings in Globe Life were worth $93,580,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. CYBER HORNET ETFs LLC acquired a new position in Globe Life in the 2nd quarter valued at about $28,000. MUFG Securities EMEA plc acquired a new position in Globe Life in the 2nd quarter valued at about $31,000. Torren Management LLC acquired a new position in Globe Life in the 4th quarter valued at about $37,000. Banque Cantonale Vaudoise acquired a new position in Globe Life in the 3rd quarter valued at about $50,000. Finally, Center for Financial Planning Inc. purchased a new stake in shares of Globe Life in the 3rd quarter valued at approximately $51,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Globe Life
In related news, CEO Frank M. Svoboda sold 20,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at $8,463,853.60. This represents a 27.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO James Matthew Darden sold 4,663 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the sale, the chief executive officer directly owned 58,451 shares in the company, valued at approximately $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 105,929 shares of company stock valued at $16,382,450 in the last 90 days. Corporate insiders own 2.11% of the company’s stock.
Analyst Ratings Changes
Globe Life Price Performance
Globe Life stock opened at $159.48 on Wednesday. The company’s 50 day simple moving average is $151.32 and its 200-day simple moving average is $143.90. The company has a market capitalization of $12.38 billion, a price-to-earnings ratio of 11.03 and a beta of 0.49. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $160.74. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.
Globe Life (NYSE:GL – Get Free Report) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the company earned $3.07 earnings per share. Globe Life’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities research analysts expect that Globe Life Inc. will post 15.62 earnings per share for the current year.
Globe Life Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is presently 9.13%.
Globe Life Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
